To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research Nov 22, 2022 13:10 HKT/SGT Read More
Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer's Disease Research at The 15th Clinical Trials on Alzheimer's Disease (CTAD) Conference Nov 21, 2022 10:50 HKT/SGT Read More
エーザイ、第15回アルツハイマー病臨床試験会議(CTAD)において抗アミロイドβ(Aβ)プロトフィブリル抗体レカネマブの臨床第III相Clarity AD検証試験の詳細結果を含むアルツハイマー病領域のパイプラインに関する最新データを発表 Nov 21, 2022 10:30 JST Read More
Fujitsu and Wakayama Medical University start joint trials for millimeter-wave sensor to detect falls of elderly patients Nov 21, 2022 09:43 HKT/SGT Read More
L'Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, launches SHIHYO, a newly created luxury beauty brand Nov 21, 2022 08:00 HKT/SGT Read More
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally Nov 18, 2022 21:00 JST Read More
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally Nov 18, 2022 20:00 HKT/SGT Read More
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis Nov 17, 2022 08:00 HKT/SGT Read More
American Journal of Gastroenterology Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis Nov 16, 2022 23:00 HKT/SGT Read More
Metoject Subcutaneous Injection Syringe (Methotrexate) Launched In Japan For Rheumatoid Arthritis Nov 16, 2022 10:46 HKT/SGT Read More
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again Nov 14, 2022 08:59 HKT/SGT Read More